MALVERN, Pa., March 04, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospitals and other acute care ...

MALVERN, Pa., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a high-performing, revenue generating contract development and manufacturing organization (CDMO), today announced that ...

With manufacturing operations already locked up in Georgia, Recro Pharma is taking its CDMO ambitions coast-to-coast. Recro has dished out nearly $50 million to acquire CDMO peer Irisys. The deal for ...

RADNOR, Pa.--(BUSINESS WIRE)--Kaskela Law LLC has filed a shareholder class action lawsuit against Recro Pharma, Inc. (NASDAQ: REPH) (“Recro” or the “Company”) on behalf of investors who purchased or ...

GAINESVILLE, Ga.--(BUSINESS WIRE)--Recro Gainesville, LLC, a wholly owned subsidiary of Recro Pharma, Inc., and a leading provider of solid oral dose manufacturing services for the pharmaceutical ...

GAINESVILLE, Ga., April 15, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. ("Recro"; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and ...

Recro Pharma Inc. plans to launch a revised study of its lead product candidate, a non-opiod painkiller called Dex-IN, after an interim analysis of Phase IIb study data showed the treatment's efficacy ...

MALVERN, Pa., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with ...

SAN DIEGO and GAINESVILLE, Ga., Jan. 19, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. ("Recro"; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex ...

Business Poised to Continue Driving Revenue and Begin Generating Profits Recro Will Continue to Trade on NASDAQ Under Ticker Symbol “REPH” MALVERN, Pa., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, ...